Zobrazeno 1 - 10
of 16
pro vyhledávání: '"David, Liebner"'
Autor:
Marium Husain, Dionisia Quiroga, Han Gil Kim, Scott Lenobel, Menglin Xu, Hans Iwenofu, James L. Chen, Claire Verschraegen, David Liebner, Gabriel Tinoco
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Despite immunotherapy’s promise in oncology, its use for sarcoma remains challenging. There are no sarcoma-specific biomarkers for immune checkpoint inhibitors (ICI). Previously, we reported our institutional experience highligh
Externí odkaz:
https://doaj.org/article/a313bc60a4274fc19fc0bd6444b4595b
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Solid organ malignancies have been reported in survivors of Hodgkin lymphoma treated with chemoradiation; however, to the best of our knowledge no cases of pulmonary synovial sarcoma have been documented in the literature in this cohort. We herein pr
Externí odkaz:
https://doaj.org/article/29f20b137725405e9914ffe0abd003ef
Autor:
Marium Husain, Luxi Chen, David Liebner, Joal Beane, Mark Rubinstein, Raphael Pollock, Claire Verschraegen, Gabriel Tinoco
Publikováno v:
The Oncologist. 28:e233-e241
Soft-tissue sarcomas (STS) are a rare and heterogeneous group of malignant tumors that arise from the oncogenic transformation of mesenchymal tissue. There are over 100 distinct STS histological and molecular subtypes with unique clinical, therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b00a7a9632e731f969e6ba6886486ca
https://doi.org/10.1093/oncolo/oyad052
https://doi.org/10.1093/oncolo/oyad052
Autor:
Margaret von Mehren, John M. Kane, Richard F. Riedel, Jason K. Sicklick, Seth M. Pollack, Mark Agulnik, Marilyn M. Bui, Janai Carr-Ascher, Edwin Choy, Mary Connelly, Sarah Dry, Kristen N. Ganjoo, Ricardo J. Gonzalez, Ashley Holder, Jade Homsi, Vicki Keedy, Ciara M. Kelly, Edward Kim, David Liebner, Martin McCarter, Sean V. McGarry, Nathan W. Mesko, Christian Meyer, Alberto S. Pappo, Amanda M. Parkes, Ivy A. Petersen, Matthew Poppe, Scott Schuetze, Jacob Shabason, Matthew B. Spraker, Melissa Zimel, Mary Anne Bergman, Hema Sundar, Lisa E. Hang
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:1204-1214
Gastrointestinal stromal tumors (GIST) are the most common type of soft tissue sarcoma that occur throughout the gastrointestinal tract. Most of these tumors are caused by oncogenic activating mutations in the KIT or PDGFRA genes. The NCCN Guidelines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51da37783b7309879e737889cfc35a68
https://doi.org/10.6004/jnccn.2022.0058
https://doi.org/10.6004/jnccn.2022.0058
Autor:
Margaret von Mehren, John M. Kane, Mark Agulnik, Marilyn M. Bui, Janai Carr-Ascher, Edwin Choy, Mary Connelly, Sarah Dry, Kristen N. Ganjoo, Ricardo J. Gonzalez, Ashley Holder, Jade Homsi, Vicki Keedy, Ciara M. Kelly, Edward Kim, David Liebner, Martin McCarter, Sean V. McGarry, Nathan W. Mesko, Christian Meyer, Alberto S. Pappo, Amanda M. Parkes, Ivy A. Petersen, Seth M. Pollack, Matthew Poppe, Richard F. Riedel, Scott Schuetze, Jacob Shabason, Jason K. Sicklick, Matthew B. Spraker, Melissa Zimel, Lisa E. Hang, Hema Sundar, Mary Anne Bergman
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN, vol 20, iss 7
Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b774e513a8e6f291da69c0b8c061e468
https://doi.org/10.6004/jnccn.2022.0035
https://doi.org/10.6004/jnccn.2022.0035
Autor:
Gurpreet Kapoor, Stefan Zajic, Sunil Suchindran, Jaegil Kim, Uma Saxena, Aishwarya Bhaskar, Heather Kaczynski, Michael Nathenson, Jimson D'Souza, Benjamin Rich, Sandra D'Angelo, Mihaela Druta, Brian Van Tine, Neeta Somaiah, David Liebner, Scott Schuetze, Ioanna Eleftheriadou
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50e345a61468fc594a656a5c54b5a416
https://doi.org/10.1136/jitc-2022-sitc2022.0601
https://doi.org/10.1136/jitc-2022-sitc2022.0601
Publikováno v:
Case Reports in Endocrinology, Vol 2016 (2016)
Objective. Thyroid disease has been reported among the endocrinopathies that can occur after treatment with ipilimumab. Graves’ disease, however, has been rarely reported with this medication. Here we report a case of Graves’ disease diagnosed af
Externí odkaz:
https://doaj.org/article/050166b2c3204f0ba72973fc5955a97a
Publikováno v:
Lecture Notes in Computer Science ISBN: 9783031164330
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f0724012158f73f1893825294db4fe0
https://doi.org/10.1007/978-3-031-16434-7_36
https://doi.org/10.1007/978-3-031-16434-7_36
Autor:
Joshua D. Palmer, Rahul N. Prasad, Denise Fabian, Lai Wei, Vedat O. Yildiz, Yubo Tan, John Grecula, Meng Welliver, Terence Williams, James B. Elder, Raju Raval, Dukagjin Blakaj, Karl Haglund, Jose Bazan, Kari Kendra, Andrea Arnett, Sasha Beyer, David Liebner, Pierre Giglio, Vinay Puduvalli, Arnab Chakravarti, Evan Wuthrick
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 170
Trametinib is a MEK inhibitor with intracranial activity indicated for BRAF-mutant metastatic malignancies. Yet, the safety of trametinib concurrent with whole brain radiation therapy (WBRT) is unknown. We performed a single-institution, prospective,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc440995ba66dd9d23b3748ee5e563c
https://pubmed.ncbi.nlm.nih.gov/35367525
https://pubmed.ncbi.nlm.nih.gov/35367525
Publikováno v:
Genes, chromosomescancerREFERENCES. 61(4)
Cutaneous fibromyxoid neoplasms (CFMN) comprise a vast category of benign and malignant tumors that include, but are not limited to, low-grade fibromyxoid sarcoma, myxofibrosarcoma, myxoid dermatofibrosarcoma protuberans, myxoid solitary fibrous tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::290b18edc9a43f8b8579e5310ee5a5d2
https://pubmed.ncbi.nlm.nih.gov/34874592
https://pubmed.ncbi.nlm.nih.gov/34874592